Acute auto-aggression syndrome following autologous hematopoietic stem cell transplant and lenalidomide for multiple myeloma.

Struble E, Ginn M, Strouse C

Open source

DOI
10.1177/10781552231185153
Published
2023 Oct
Container
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/10781552231185153,
  title = {Acute auto-aggression syndrome following autologous hematopoietic stem cell transplant and lenalidomide for multiple myeloma.},
  author = {Struble E and Ginn M and Strouse C},
  year = {2023},
  journal = {Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners},
  doi = {10.1177/10781552231185153},
  url = {https://doi.org/10.1177/10781552231185153}
}

RIS

TY  - JOUR
TI  - Acute auto-aggression syndrome following autologous hematopoietic stem cell transplant and lenalidomide for multiple myeloma.
AU  - Struble E
AU  - Ginn M
AU  - Strouse C
PY  - 2023
JO  - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
DO  - 10.1177/10781552231185153
UR  - https://doi.org/10.1177/10781552231185153
ER  - 

APA

E, S., M, G., & C, S. (2023). Acute auto-aggression syndrome following autologous hematopoietic stem cell transplant and lenalidomide for multiple myeloma.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. https://doi.org/10.1177/10781552231185153

Source records